BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25521201)

  • 1. Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma.
    Song R; Liu Q; Hutvagner G; Nguyen H; Ramamohanarao K; Wong L; Li J
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S16. PubMed ID: 25521201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
    Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
    Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
    Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
    Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma.
    Wang J; Li Z; Ge Q; Wu W; Zhu Q; Luo J; Chen L
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1404-14.e4. PubMed ID: 25813410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microRNA in human lung squamous cell carcinoma.
    Yang Y; Li X; Yang Q; Wang X; Zhou Y; Jiang T; Ma Q; Wang YJ
    Cancer Genet Cytogenet; 2010 Jul; 200(2):127-33. PubMed ID: 20620595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers.
    Xing L; Todd NW; Yu L; Fang H; Jiang F
    Mod Pathol; 2010 Aug; 23(8):1157-64. PubMed ID: 20526284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
    Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
    Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connecting rules from paired miRNA and mRNA expression data sets of HCV patients to detect both inverse and positive regulatory relationships.
    Song R; Liu Q; Liu T; Li J
    BMC Genomics; 2015; 16 Suppl 2(Suppl 2):S11. PubMed ID: 25707620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
    Muñoz-Largacha JA; Gower AC; Sridhar P; Deshpande A; O'Hara CJ; Yamada E; Godfrey TE; Fernando HC; Litle VR
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):714-727. PubMed ID: 28495058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.